Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Implantable cardioverter-defibrillator (ICD) therapy has been shown to improve survival in patients with various heart conditions who are at high risk for ventricular arrhythmias. Whether benefit occurs in patients early after myocardial infarction is unknown. METHODS: We conducted the Defibrillator in Acute Myocardial Infarction Trial, a randomized, open-label comparison of ICD therapy (in 332 patients) and no ICD therapy (in 342 patients) 6 to 40 days after a myocardial infarction. We enrolled patients who had reduced left ventricular function (left ventricular ejection fraction, 0.35 or less) and impaired cardiac autonomic function (manifested as depressed heart-rate variability or an elevated average 24-hour heart rate on Holter monitoring). The primary outcome was mortality from any cause. Death from arrhythmia was a predefined secondary outcome. RESULTS: During a mean (+/-SD) follow-up period of 30+/-13 months, there was no difference in overall mortality between the two treatment groups: of the 120 patients who died, 62 were in the ICD group and 58 in the control group (hazard ratio for death in the ICD group, 1.08; 95 percent confidence interval, 0.76 to 1.55; P=0.66). There were 12 deaths due to arrhythmia in the ICD group, as compared with 29 in the control group (hazard ratio in the ICD group, 0.42; 95 percent confidence interval, 0.22 to 0.83; P=0.009). In contrast, there were 50 deaths from nonarrhythmic causes in the ICD group and 29 in the control group (hazard ratio in the ICD group, 1.75; 95 percent confidence interval, 1.11 to 2.76; P=0.02). CONCLUSIONS: Prophylactic ICD therapy does not reduce overall mortality in high-risk patients who have recently had a myocardial infarction. Although ICD therapy was associated with a reduction in the rate of death due to arrhythmia, that was offset by an increase in the rate of death from nonarrhythmic causes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite data linking decreased HRV with increased mortality, randomized trials in patients stratified for ICD implantation based on this parameter failed to demonstrate the usefulness of HRV in predicting benefit from ICD therapy (Hohnloser et al., 2004;Steinbeck et al., 2009).”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Hohnloser et al., 2004
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
Kleiger, R. E., Miller, J. P., Bigger, J. T., & Moss, A. J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90795-8 · Cited by 3,995
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
The DAVID Trial Investigators* (2002) · JAMA · doi:10.1001/jama.288.24.3115 · Cited by 2,056
Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., Green, M. S., Klein, G. J., & O’Brien, B. (2000) · Circulation · doi:10.1161/01.cir.101.11.1297 · Cited by 1,607
Self-citationBigger, J. T., Fleiss, J. L., Kleiger, R., Miller, J. P., & Rolnitzky, L. M. (1984) · Circulation · doi:10.1161/01.cir.69.2.250 · Cited by 1,286
Research works printed but not linked: 3
- Myerburg RJ, 1992, Circulation, 85, I
- Zuanetti G, 1999, Eur Heart J, 1, H52
- Mantel N, 1966, Cancer Chemother Rep, 50, 163
Cited by
Items 701–800 of 1,000
Foo, F. S., Lee, M., Looi, K., Larsen, P., Clare, G. C., Heaven, D., Stiles, M. K., Voss, J., Boddington, D., Jackson, R., et al. (2019) · Journal of Arrhythmia · doi:10.1002/joa3.12244 · Cited by 9
Søholm, H., Laursen, M. L., Kjærgaard, J., Lindhardt, T. B., Hassager, C., Møller, J. E., Gregers, E., Linde, L., Johansen, J. B., Winther‐Jensen, M., et al. (2021) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2021.1900597 · Cited by 9
Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies
Siddiqui, A. H., & Kowey, P. R. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.hco.0000240591.06839.39 · Cited by 9
Botto, G. L., Luzi, M., Ruffa, F., RUSSO, G., & Ferrari, G. M. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00489.x · Cited by 9
The Role of Aldosterone Blockade in Patients with Heart Failure
Pitt, B. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2352-2 · Cited by 9
Angiotensin Receptor Antagonists to Prevent Sudden Death in Heart Failure: Does the Dose Matter?
Francia, P., Palano, F., Tocci, G., Adduci, C., Ricotta, A., Semprini, L., Caprinozzi, M., Balla, C., & Volpe, M. (2014) · ISRN Cardiology · doi:10.1155/2014/652421 · Cited by 9
Ito, I., Koichi, K. O. N. O., Shinbo, G., Tadokoro, K., Chikara, A. B. E., TAKEMURA, N., Iemura, T., Matsuhashi, N., Nakano, N., Satoshi, O. T. A., et al. (2009) · Hemodialysis International · doi:10.1111/j.1542-4758.2009.00330.x · Cited by 9
Jøns, C., & Thomsen, P. E. B. (2011) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-011-0163-4 · Cited by 9
Omoumi, P., Metais, J. P., Bertrand, P., & Alison, D. (2010) · Journal de Radiologie · doi:10.1016/s0221-0363(10)70114-1 · Cited by 9
Team-Based Care for Managing Cardiac Comorbidities in Heart Failure
Bellam, N., Kelkar, A. A., & Whellan, D. J. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.03.005 · Cited by 9
Testing each hypothesis marginally at alpha while still controlling FWER: how and when
Li, J. (2012) · Statistics in Medicine · doi:10.1002/sim.5488 · Cited by 9
Al‐Khatib, S. M., Hafley, G. E., Lee, K. L., & Buxton, A. E. (2010) · EP Europace · doi:10.1093/europace/euq116 · Cited by 9
Arrhythmias in the Coronary Care Unit
Badhwar, N., Kusumoto, F. M., & Goldschlager, N. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066611402165 · Cited by 9
Long-term performance of the Medtronic Sprint Fidelis lead: a matter of lead type?
Frey, S., Sticherling, C., Bucher, U., Widmer, R., Ammann, P., Kühne, M., Osswald, S., & Schaer, B. A. (2012) · EP Europace · doi:10.1093/europace/eus181 · Cited by 9
Canadian Cardiovascular Society Consensus Conference Recommendations on Heart Failure 2006
Tsuyuki, R. T., & Arnold, J. M. O. (2006) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/171516350613900306 · Cited by 9
Sudden death prophylaxis in heart failure
Rosanio, S., Schwarz, E. R., Vitarelli, A., Zarraga, I. G. E., Kunapuli, S., Ware, D. L., Birnbaum, Y., Tuero, E., & Uretsky, B. F. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.021 · Cited by 9
A 59-Year-Old Man Considering Implantation of a Cardiac Defibrillator
ZIMETBAUM, P. J. (2007) · JAMA · doi:10.1001/jama.297.17.1909 · Cited by 9
The Implantable Cardioverter Defibrillator
Gold, M. R. (2005) · Wiley eBooks · doi:10.1002/9780470750674.ch8 · Cited by 9
Arya, A., Haghjoo, M., & Sadr‐Ameli, M. A. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.05.011 · Cited by 9
VersorgungsLeitlinie, N. (2013) · Cited by 9
Wearable Cardioverter–Defibrillator after Myocardial Infarction
Fauchier, L., Clémenty, N., & Bisson, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1816889 · Cited by 9
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Rimskaya, E. M., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-2-6-76 · Cited by 8
Anastasiou, V., Daios, S., Moysidis, D. V., Liatsos, A. C., Papazoglou, Α. S., Didagelos, M., Savopoulos, C. G., Bax, J. J., Ziakas, A., & Kamperidis, V. (2024) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2024.07.002 · Cited by 8
Kontogiannis, V., Goromonzi, F., Both, B., Semrau, F., Branagan-Harris, M., Atkinson, J., Roberts, P. R., & Javanbakht, M. (2025) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00553-z · Cited by 8
Dotsenko, O., Barsheshet, A., & Huang, D. T.-C. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.120 · Cited by 8
Effects of Cardiac Stem Cell on Postinfarction Arrhythmogenic Substrate
Arenal, Á., Ríos-Muñoz, G. R., Carta‐Bergaz, A., Ruíz-Hernández, P. M., David, E. P., Crisóstomo, V., Loughlin, G., y, R. S.-R., Fernández‐Portales, J., Acosta, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416211 · Cited by 8
Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
Younis, A., & Wilkoff, B. L. (2023) · JACC Asia · doi:10.1016/j.jacasi.2022.11.014 · Cited by 8
Krahn, A. D., Hoch, J. S., Rockx, M. A., Leong‐Sit, P., Gula, L. J., Yee, R. K., Skanes, A. C., & Klein, G. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.067 · Cited by 8
Durak, I., Kudaiberdieva, G., & Görenek, B. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.987127 · Cited by 8
Schaer, B. A., Sticherling, C., Szili‐Törok, T., Osswald, S., Jordaens, L. J. L. M., & Theuns, D. A. M. J. (2011) · EP Europace · doi:10.1093/europace/eur169 · Cited by 8
BAYESIAN META-ANALYSIS ON MEDICAL DEVICES: APPLICATION TO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
Youn, J.-H., Lord, J., Hemming, K., Girling, A. J., & Buxton, M. J. (2012) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462312000037 · Cited by 8
Zhao, D. X.-M., Radford, J., Tamis‐Holland, J. E., Tommaso, C. L., Tracy, C. M., Linderbaum, J. A., Morrow, D. A., Newby, L. K., Ornato, J. P., Fesmire, F. M., et al. (2014) · Cited by 8
Sipahi, İ., Chaudhry, S., Issa, M., Ambati, M., Dağdelen, S., & Fang, J. C. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283657524 · Cited by 8
van der Lingen, A. C. J., Timmer, S. A. J., Allaart, L. J. H., Rijnierse, M. T., van de Ven, P. M., van Rossum, A. C., Kemme, M. J. B., van Halm, V. P., & Allaart, C. P. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.05.026 · Cited by 8
Rusnak, J., Behnes, M., Weiß, C., Nienaber, C. A., Reiser, L., Schupp, T., Bollow, A., Taton, G., Reichelt, T., Ellguth, D., et al. (2020) · Cardiology · doi:10.1159/000504876 · Cited by 8
Deckers, J. W., Arshi, B., van den Berge, J. C., & Constantinescu, A. A. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13506 · Cited by 8
Abumayyaleh, M., Dreher, T. C., Rosenkaimer, S., Röger, S., Erath, J. W., Klein, N., Kovacs, B., Duru, F., Saguner, A. M., El‐Battrawy, I., et al. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15648 · Cited by 8
Gómez‐Mesa, J. E., Márquez-Murillo, M. F., Figueiredo, M. J. D. O., Berni-Betancourt, A., Jerez, A. M., Ayala, E. N., Pow-Chon-Long, F., Sáenz-Morales, L. C., Molano, L. F. P., Montes, M. C., et al. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01425-4 · Cited by 8
Kaiser, D. W., Tsai, V., Heidenreich, P. A., Goldstein, M. K., Wang, Y., Curtis, J. P., & Turakhia, M. P. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.010 · Cited by 8
Sjöblom, J., Ljung, L., Frick, M., Rosenqvist, M., & Frykman, V. (2011) · EP Europace · doi:10.1093/europace/eur354 · Cited by 8
Electronic cardiac medicine: present and future opportunities
Auricchio, A., & Moccetti, T. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.13052 · Cited by 8
Heart Rate Variability and Cardiac Diseases
Watanabe, E., Kiyono, K., Yamamoto, Y., & Hayano, J. (2016) · Springer eBooks · doi:10.1007/978-4-431-56012-8_10 · Cited by 8
Khan, H., & Leslie, S. J. (2019) · World Journal of Cardiology · doi:10.4330/wjc.v11.i3.103 · Cited by 8
Aldosterone blockade in post‐acute myocardial infarction heart failure
Pitt, B., Ferrari, R., Gheorghiade, M., van Veldhuisen, D. J., Krum, H., McMurray, J. J. V., & López-Sendón, J. (2006) · Clinical Cardiology · doi:10.1002/clc.4960291004 · Cited by 8
Lim, H. S., Lip, G. Y. H., & Tse, H. (2008) · EP Europace · doi:10.1093/europace/eun070 · Cited by 8
Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree
Shen, C., Hu, Y., Li, X., Wang, Y., Chen, P., & Buxton, A. E. (2016) · Biometrical Journal · doi:10.1002/bimj.201500180 · Cited by 8
The wearable cardioverter-defibrillator vest: Indications and ongoing questions
Sandhu, U. G., Rajyaguru, C. P., Cheung, C. C., Morin, D. P., & Lee, B. K. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.05.005 · Cited by 8
Indicaciones actuales del desfibrilador automático implantable
González‐Torrecilla, E. (2008) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(08)73533-7 · Cited by 8
Antiarrhythmic Drugs for All Patients With an ICD?
Page, R. L. (2006) · JAMA · doi:10.1001/jama.295.2.211 · Cited by 8
Primary prevention with ICDs, are we on the right track?
Wilde, A. A. M., & Simmers, T. A. (2009) · Netherlands Heart Journal · doi:10.1007/bf03086225 · Cited by 8
Pedretti, R. F. E., Craenenbroeck, E. M. V., Vrints, C., Ambrosetti, M., Kurpas, D., Vassiliou, V. S., Bäck, M., Moholdt, T. T., Sionís, A., Wilhelm, M., et al. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag236 · Cited by 7
Lewsey, S. C., Martyn, T., Blumer, V. L., Brownell, N. K., Denfeld, Q. E., Dunlay, S. M., Goyal, P., Halloway, S., Matlock, D., Vardeny, O., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001437 · Cited by 7
Mountantonakis, S., & Hutchinson, M. D. (2011) · Current Heart Failure Reports · doi:10.1007/s11897-011-0069-1 · Cited by 7
Huang, J., Bhatia, N. K., Lloyd, M. S., Westerman, S. B., Shah, A., Leal, M., DeLurgio, D. B., Patel, A. M., TOMPKINS, C. M., León, A. R., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.10.048 · Cited by 7
Kandzari, D. E., Perumal, R., & Bhatt, D. L. (2016) · Clinical Cardiology · doi:10.1002/clc.22544 · Cited by 7
Rusnak, J., Behnes, M., Weiß, C., Nienaber, C. A., Reiser, L., Schupp, T., Bollow, A., Taton, G., Reichelt, T., Ellguth, D., et al. (2020) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2020.02.009 · Cited by 7
E/e' in relation to outcomes in ST‐elevation myocardial infarction
Tai, S. B., Lau, W. R., Gao, F., Hamid, N. B., Amanullah, M. R., Fam, J. M., Yap, J. J. L., Ewe, S. H., Chan, M. Y., Yeo, K. K., et al. (2020) · Echocardiography · doi:10.1111/echo.14652 · Cited by 7
Sudden cardiac death prevention in the era of novel heart failure medications
Koev, I., Yarkoni, M., Luria, D. M., Amir, O., & Biton, Y. (2023) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2023.100281 · Cited by 7
Iliodromitis, K. E., Balogh, Z., Triposkiadis, F. K., Deftereos, S. G., Vrachatis, D. A., Bimpong‐Buta, N., Schiedat, F., & Bogossian, H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1176710 · Cited by 7
Smith, T. W., van Dessel, P. F. H. M., Theuns, D. A. M. J., Muskens, A. J. Q. M., van Domburg, R. T., Wilde, A. A. M., & Jordaens, L. J. L. M. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0176-3 · Cited by 7
Tsai, E. J., Wilkoff, B. L., Mitchell, J. E., Peterson, P. N., Riegel, B. J., Sam, F., Kasper, E. K., Levy, W. C., Masoudi, F. A., McBride, P. E., et al. (2013) · Cited by 7
Hioki, H., Kozuma, K., Kobayashi, Y., Andò, K., Morino, Y., Kishihara, J., Ako, J., & Ikari, Y. (2021) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-021-00788-1 · Cited by 7
Sudden cardiac death - a known unknown?
Obrová, J., Sovová, E., Kociánová, E., & Táborský, M. (2021) · Biomedical Papers · doi:10.5507/bp.2021.065 · Cited by 7
(2009) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2009001400001 · Cited by 7
Lambiase, P. D., & Maclean, E. (2023) · Heart · doi:10.1136/heartjnl-2022-322122 · Cited by 7
Garg, M., Gupta, M., Patel, N. N., Bansal, K., Lam, P. H., & Sheikh, F. H. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.08.145 · Cited by 7
Consenso de Insuficiencia Cardíaca Aguda y Avanzada
Cardíaca, C. D. I., & Barisani, J. L. (2025) · Revista Argentina de Cardiología · doi:10.7775/rac.v77i3.2222 · Cited by 7
The Role of Cardiac Electrophysiology in Myocardial Regenerative Stem Cell Therapy
Huang, G., Pashmforoush, M., Chung, B., & Saxon, L. A. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9239-x · Cited by 7
Hoogslag, G. E., Thijssen, J., Höke, U., Boden, H., Antoni, M. L., Debonnaire, P., Haeck, M. L. A., Holman, E. R., Bax, J. J., Marsan, N. A., et al. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0412-4 · Cited by 7
Wood shop, Sun Tzu, and patient selection for cardiac resynchronization therapy
Sweeney, M. O. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.03.013 · Cited by 7
Conelius, J. (2013) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31824b2105 · Cited by 7
CRT-D use in heart failure: too little or too much?
Hohnloser, S. H., & Prystowsky, E. N. (2007) · European Heart Journal Supplements · doi:10.1093/eurheartj/sum048 · Cited by 7
Self-citationRecent primary prevention implantable cardioverter defibrillator trials
Duray, G. Z., Israel, C. W., & Hohnloser, S. H. (2005) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000198978.55637.b5 · Cited by 7
Self-citationDreher, T. C., El‐Battrawy, I., Röger, S., Rosenkaimer, S., Gerhards, S., Kuschyk, J., Borggrefe, M. M., & Akın, İ. (2020) · In Vivo · doi:10.21873/invivo.12205 · Cited by 7
End-stage chronic heart failure
Leibundgut, G., & Rocca, H. B. (2007) · Swiss Medical Weekly · doi:10.4414/smw.2007.11673 · Cited by 7
Baczkó, I., Leprán, I., Kiss, L., Muntean, D. M., & Light, P. E. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141029101305 · Cited by 7
Lewis, G. F., Harless, A. C., Vazquez, L. D., ABI‐SAMRA, F. M., Bernard, M. L., Khatib, S., Polin, G. M., & Morin, D. P. (2015) · Clinical Cardiology · doi:10.1002/clc.22477 · Cited by 7
Who Benefits From a Defibrillator—Balancing the Risk of Sudden Versus Non-sudden Death
Beggs, S. A. S., Gardner, R. S., & McMurray, J. J. V. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0416-6 · Cited by 7
Nonsustained Ventricular Tachycardia
Katritsis, D. G., Zaręba, W., & Camm, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00045-4 · Cited by 7
Ajello, L., Coppola, G., Corrado, E., Franca, E. L., Rotolo, A., & Assennato, P. (2013) · ISRN Cardiology · doi:10.1155/2013/731285 · Cited by 7
AICD treatment in 2004--state of the art.
Budde, T. (2006) · PubMed · Cited by 7
Brandimarte, F., Blair, J. E., Manuchehry, A., Fedele, F., & Gheorghiade, M. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2007.08.011 · Cited by 7
Heart rate variability in patients with stable angina pectoris
Björkander, I. (2009) · Figshare · Cited by 7
The Wearable Cardioverter-Defibrillator
Verdino, R. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.015 · Cited by 7
Lombardi, F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi314 · Cited by 7
Goldberger, J. J., & Hendel, R. C. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004275 · Cited by 7
Deterrence Effects of Antifraud and Abuse Enforcement in Health Care
Howard, D. H., & McCarthy, I. (2020) · National Bureau of Economic Research · doi:10.3386/w27900 · Cited by 7
Virbickiene, A., Lapinskas, T., Garlichs, C. D., Mattecka, S., Tanacli, R., Ries, W., Torzewski, J., Heigl, F., Pfluecke, C., Darius, H., et al. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10070294 · Cited by 6
Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo
Ponte-Negretti, C. I., Zaidel, E. J., López-Santi, R., Múnera, A. G., Bryce, A., M, S. N., Espinoza, J., Gaibor, J. C., Valcárcel, Y., Antonio, C. D., et al. (2024) · Archivos de cardiología de México · doi:10.24875/acm.m24000096 · Cited by 6
Şahin, A., Çelik, A., Ural, D., Çöllüoğlu, T., Ata, N., Kanik, E. A., Ülgü, M. M., Birinci, Ş., & Yılmaz, M. B. (2024) · BMC Medicine · doi:10.1186/s12916-024-03761-w · Cited by 6
Pukkila, T., Rankinen, J., Lyytikäinen, L., Oksala, N., Nikus, K., Räsänen, E., & Hernesniemi, J. A. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101619 · Cited by 6
Song, J., Fan, Z., Bo, Y., Taiwaikuli, D., He, J., Zhang, X., Ji, S., Chen, Y., Ding, H., Wu, H., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103016 · Cited by 6
Ischemic Cardiomyopathy: Contemporary Clinical Management
Alkar, B. S., Mattsson, G., & Magnusson, P. (2018) · InTech eBooks · doi:10.5772/intechopen.76723 · Cited by 6
Minami, Y., Kikuchi, N., Shiga, T., Suzuki, A., Shoda, M., & Hagiwara, N. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12618 · Cited by 6
Rohrer, U., Manninger, M., Fiedler, L., Steinwender, C., Binder, R. K., Stuehlinger, M., Zirngast, B., Zweiker, D., Zirlik, A., & Scherr, D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12155029 · Cited by 6
Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
Leong, A. M., Arnold, A. D., & Whinnett, Z. I. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11030092 · Cited by 6
Biventricular Pacing and Defibrillator Use in Chronic Heart Failure
Cesario, D. A., Turner, J. W., & Dec, G. W. (2007) · Cardiology Clinics · doi:10.1016/j.ccl.2007.09.002 · Cited by 6
Risk Stratification for Prevention of Sudden Cardiac Death
Saha, P., & Goldberger, J. J. (2011) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-011-0160-7 · Cited by 6
González‐Enríquez, S., Rodríguez‐Entem, F., Expósito, V., Castrillo-Bustamante, C., Canteli, Á., Martínez, Á. S., Madrazo, I., & Olalla, J. J. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9735-9 · Cited by 6
Indikationen für den implantierbaren Cardioverter/Defibrillator (ICD)
Schwab, J. O., & Lüderitz, B. (2007) · Der Internist · doi:10.1007/s00108-007-1871-4 · Cited by 6
Metadata
- Authors
- Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J.
- Affiliations
- Goethe University Frankfurt (DE)
- St. Michael's Hospital (CA)
- University of Nottingham (GB)
- McMaster University (CA)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-12-09
- Volume
- 351
- Issue
- 24
- Pages
- 2481-2488
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2109205604
- Cited by
- 1,519
- References
- 22
- Citations by year
- 2026: 23 · 2025: 24 · 2024: 32 · 2023: 39 · 2022: 50 · 2021: 54 · 2020: 53 · 2019: 59 · 2018: 52 · 2017: 93 · 2016: 67 · 2015: 75 · 2014: 70 · 2013: 93 · 2012: 96
- FWCI
- 52.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, acute myocardial infarction, all-cause mortality, left ventricular dysfunction, heart rate variability
- MeSH terms
- Adult, Aged, Arrhythmias, Cardiac, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Risk, Stroke Volume, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.